CircCNIH4 inhibits gastric cancer progression via regulating DKK2 and FRZB expression and Wnt/β-catenin pathway

Qi Shi1, Chuanwen Zhou1, Rui Xie1

  • 1Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, No. 1, West Huanghe Road, Huaian, 223300, Jiangsu, China.

Abstract

Insights

Circular RNAs (circRNAs) like circCNIH4 inhibit gastric cancer progression. Upregulating circCNIH4 increases DKK2 and FRZB, suppressing the Wnt/β-catenin pathway, offering a potential diagnostic and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in tumor progression across various cancers, including gastric cancer.
  • Gastric cancer remains a significant global health concern, necessitating novel therapeutic targets and biomarkers.
  • Understanding the specific roles of circRNAs in gastric cancer is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of circCNIH4 (hsa_circ_0000190) in gastric cancer.
  • To elucidate the underlying molecular mechanisms by which circCNIH4 influences gastric cancer.
  • To assess the potential of circCNIH4 as a biomarker for gastric cancer diagnosis and treatment.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Western blot to measure protein levels of key pathway components and proliferation markers.
  • In vitro (cell culture) and in vivo (animal models) experiments to assess functional roles in proliferation, apoptosis, migration, and invasion.

Main Results:

  • CircCNIH4 expression was significantly downregulated in gastric cancer tissues and cells.
  • Overexpression of circCNIH4 inhibited gastric cancer cell proliferation, migration, and invasion, while promoting apoptosis.
  • CircCNIH4 inactivated the Wnt/β-catenin pathway by upregulating Dickkopf 2 (DKK2) and Frizzled related protein (FRZB) expression, suppressing tumor growth both in vitro and in vivo.

Conclusions:

  • CircCNIH4 acts as a tumor suppressor in gastric cancer.
  • Upregulation of circCNIH4 inhibits gastric cancer progression by enhancing DKK2 and FRZB expression and suppressing the Wnt/β-catenin pathway.
  • CircCNIH4 holds promise as a potential biomarker for the diagnosis and treatment of gastric cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K